{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:21:00Z","timestamp":1777681260655,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,11,20]],"date-time":"2008-11-20T00:00:00Z","timestamp":1227139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00345-008-0350-4","type":"journal-article","created":{"date-parts":[[2008,11,19]],"date-time":"2008-11-19T16:56:57Z","timestamp":1227113817000},"page":"277-283","source":"Crossref","is-referenced-by-count":25,"title":["Prognostic significance of non-papillary tumor morphology as a predictor of cancer progression and survival in patients with primary T1G3 bladder cancer"],"prefix":"10.1007","volume":"27","author":[{"given":"Jinsung","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryn","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Hyuk","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bong-Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Mee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choung-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanjong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,20]]},"reference":[{"key":"350_CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-5347(17)43864-X","volume":"137","author":"G Jakse","year":"1987","unstructured":"Jakse G, Loidl W, Seeber G, Hofstadter F (1987) Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? J Urol 137:39\u201343","journal-title":"J Urol"},{"key":"350_CR2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0022-5347(17)36724-1","volume":"148","author":"MS Cookson","year":"1992","unstructured":"Cookson MS, Sarosdy MF (1992) Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy. J Urol 148:797\u2013801","journal-title":"J Urol"},{"key":"350_CR3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0090-4295(98)00369-0","volume":"52","author":"J Baniel","year":"1998","unstructured":"Baniel J, Grauss D, Engelstein D, Sella A (1998) Intravesical bacillus Calmette-Guerin treatment for Stage T1 grade 3 transitional cell carcinoma of the bladder. Urology 52:785\u2013789. doi: 10.1016\/S0090-4295(98)00369-0","journal-title":"Urology"},{"key":"350_CR4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0090-4295(01)01603-X","volume":"59","author":"V Pansadoro","year":"2002","unstructured":"Pansadoro V, Emiliozzi P, de Paula F, Scarpone P, Pansadoro A, Sternberg CN (2002) Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-year experience. Urology 59:227\u2013231. doi: 10.1016\/S0090-4295(01)01603-X","journal-title":"Urology"},{"key":"350_CR5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0022-5347(17)39544-7","volume":"144","author":"SB Malkowicz","year":"1990","unstructured":"Malkowicz SB, Nichols P, Lieskovsky G, Boyd SD, Huffman J, Skinner DG (1990) The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2). J Urol 144:641\u2013645","journal-title":"J Urol"},{"key":"350_CR6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0022-5347(05)65969-1","volume":"166","author":"SC Dutta","year":"2001","unstructured":"Dutta SC, Smith JA Jr, Shappell SB, Coffey CS, Chang SS, Cookson MS (2001) Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 166:490\u2013493. doi: 10.1016\/S0022-5347(05)65969-1","journal-title":"J Urol"},{"key":"350_CR7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-5347(05)67975-X","volume":"163","author":"F Millan-Rodriguez","year":"2000","unstructured":"Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodriguez J (2000) Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 163:73\u201378. doi: 10.1016\/S0022-5347(05)67975-X","journal-title":"J Urol"},{"key":"350_CR8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0090-4295(99)00116-8","volume":"54","author":"R Hurle","year":"1999","unstructured":"Hurle R, Losa A, Manzetti A, Lembo A (1999) Intravesical bacille Calmette-Guerin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-up. Urology 54:258\u2013263. doi: 10.1016\/S0090-4295(99)00116-8","journal-title":"Urology"},{"key":"350_CR9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW, Kurth K (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466\u2013475. doi: 10.1016\/j.eururo.2005.12.031 (discussion 475\u2013477)","journal-title":"Eur Urol"},{"key":"350_CR10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0302-2838(02)00173-2","volume":"41","author":"JJ Patard","year":"2002","unstructured":"Patard JJ, Rodriguez A, Leray E, Rioux-Leclercq N, Guille F, Lobel B (2002) Intravesical Bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours. Eur Urol 41:635\u2013641. doi: 10.1016\/S0302-2838(02)00173-2 (discussion 642)","journal-title":"Eur Urol"},{"key":"350_CR11","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0022-5347(05)65168-3","volume":"167","author":"S Holmang","year":"2002","unstructured":"Holmang S, Johansson SL (2002) Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression. J Urol 167:1634\u20131637. doi: 10.1016\/S0022-5347(05)65168-3","journal-title":"J Urol"},{"key":"350_CR12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-5347(17)69257-7","volume":"61","author":"JR McDonald","year":"1948","unstructured":"McDonald JR, Thompson GJ (1948) Carcinoma of the urinary bladder: a pathological study with special references to invasiveness and vascular invasion. J Urol 61:435\u2013445","journal-title":"J Urol"},{"key":"350_CR13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jjco\/hyf103","volume":"32","author":"T Saika","year":"2002","unstructured":"Saika T, Tsushima T, Nasu Y, Arata R, Kaku H, Kusaka N, Kumon H (2002) Clinical study of G3 superficial bladder cancer without concomitant CIS treated with conservative therapy. Jpn J Clin Oncol 32:461\u2013465. doi: 10.1093\/jjco\/hyf103","journal-title":"Jpn J Clin Oncol"},{"key":"350_CR14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-5347(05)64044-X","volume":"169","author":"O Shahin","year":"2003","unstructured":"Shahin O, Thalmann GN, Rentsch C, Mazzucchelli L, Studer UE (2003) A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol 169:96\u2013100. doi: 10.1016\/S0022-5347(05)64044-X (discussion 100)","journal-title":"J Urol"},{"key":"350_CR15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1046\/j.1464-410X.1997.00431.x","volume":"80","author":"HW Herr","year":"1997","unstructured":"Herr HW (1997) Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome. Br J Urol 80:762\u2013765","journal-title":"Br J Urol"},{"key":"350_CR16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.ju.0000132129.87598.3b","volume":"172","author":"GN Thalmann","year":"2004","unstructured":"Thalmann GN, Markwalder R, Shahin O, Burkhard FC, Hochreiter WW, Studer UE (2004) Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol 172:70\u201375. doi: 10.1097\/01.ju.0000132129.87598.3b","journal-title":"J Urol"},{"key":"350_CR17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.eururo.2007.06.030","volume":"53","author":"S Denzinger","year":"2008","unstructured":"Denzinger S, Fritsche HM, Otto W, Blana A, Wieland WF, Burger M (2008) Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach? Eur Urol 53:146\u2013152. doi: 10.1016\/j.eururo.2007.06.030","journal-title":"Eur Urol"},{"key":"350_CR18","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0022-5347(05)67523-4","volume":"163","author":"M Brake","year":"2000","unstructured":"Brake M, Loertzer H, Horsch R, Keller H (2000) Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin. J Urol 163:1697\u20131701. doi: 10.1016\/S0022-5347(05)67523-4","journal-title":"J Urol"},{"key":"350_CR19","first-page":"246","volume":"173","author":"CT Lee","year":"2005","unstructured":"Lee CT, Montie JE, Zhang YX, Dunn RL, Wood DP (2005) Lymphovascular invasion is an independent predictor of survival in cT1 bladder cancer. J Urol 173:246. doi: 10.1097\/01.ju.0000152317.72166.df (abstract 911)","journal-title":"J Urol"},{"key":"350_CR20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.ju.0000099825.98542.a8","volume":"171","author":"C Kwak","year":"2004","unstructured":"Kwak C, Ku JH, Park JY, Lee E, Lee SE, Lee C (2004) Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer. J Urol 171:149\u2013152. doi: 10.1097\/01.ju.0000099825.98542.a8","journal-title":"J Urol"},{"key":"350_CR21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0090-4295(98)00480-4","volume":"53","author":"K Gohji","year":"1999","unstructured":"Gohji K, Nomi M, Okamoto M, Takenaka A, Hara I, Okada H, Arakawa S, Fujii A, Kamidono S (1999) Conservative therapy for stage T1b, grade 3 transitional cell carcinoma of the bladder. Urology 53:308\u2013313. doi: 10.1016\/S0090-4295(98)00480-4","journal-title":"Urology"},{"key":"350_CR22","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/S0022-5347(01)66692-8","volume":"154","author":"V Pansadoro","year":"1995","unstructured":"Pansadoro V, Emiliozzi P, Defidio L, Donadio D, Florio A, Maurelli S, Lauretti S, Sternberg CN (1995) Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results. J Urol 154:2054\u20132058. doi: 10.1016\/S0022-5347(01)66692-8","journal-title":"J Urol"},{"key":"350_CR23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000019664","volume":"34","author":"T Lebret","year":"1998","unstructured":"Lebret T, Gaudez F, Herve JM, Barre P, Lugagne PM, Botto H (1998) Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success. Eur Urol 34:67\u201372. doi: 10.1159\/000019664","journal-title":"Eur Urol"},{"key":"350_CR24","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0022-5347(01)66043-9","volume":"155","author":"GK Zhang","year":"1996","unstructured":"Zhang GK, Uke ET, Sharer WC, Borkon WD, Bernstein SM (1996) Reassessment of conservative management for stage T1N0M0 transitional cell carcinoma of the bladder. J Urol 155:1907\u20131909. doi: 10.1016\/S0022-5347(01)66043-9","journal-title":"J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-008-0350-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-008-0350-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-008-0350-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:35:43Z","timestamp":1559050543000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-008-0350-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,20]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["350"],"URL":"https:\/\/doi.org\/10.1007\/s00345-008-0350-4","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,20]]}}}